Greg Parker
Senior Director - Biology Plexium Inc.
Seminars
Tuesday 28th October 2025
Preclinical Characterization of PLX-61639, a Potent, Selective & Oral SMARCA2 Monovalent Direct Degrader
5:00 pm
